Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tsinghua Deren (Beijing) Pharmaceutical Co., Ltd. is a specialized pharmaceutical enterprise that grew out of the research initiatives at Tsinghua University. The company is dedicated to the modernization of Traditional Chinese Medicine (TCM) and the development of high-quality chemical drugs, with a core focus on cardiovascular, cerebrovascular, and metabolic health. Its flagship products, marketed under the Deren and Aisheng brands, include treatments for hyperlipidemia and other chronic vascular conditions. Tsinghua Deren maintains a comprehensive value chain encompassing independent R&D, large-scale GMP manufacturing, and a robust domestic distribution network. By combining academic excellence with industrial expertise, the company continues to innovate in the fields of natural product extraction and modern drug formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tsinghua Deren.